Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …

In recent years, there has been growing interest in the possible use of nutraceuticals to
improve and optimize dyslipidemia control and therapy. Based on the data from available …

Introduction: Cardiovascular diseases are one of the highest causes of death and disability
in industrialized countries, whereas a large portion of patients in primary prevention have …

The present review provides an up-to-date summary of the findings on the lipid-lowering
effects of the most important nutraceuticals and functional foods. Based on current …

Compelling evidence supports the effectiveness of the reduction of total and LDL cholesterol
(TC and LDL-C) in primarily preventing cardiovascular events, within the framework of life …

Dyslipidaemia is characterized by increased blood levels of total or LDL cholesterol and
triglycerides, or decreased HDL cholesterol levels, and is a risk factor for cardiovascular …

Background Cardiovascular diseases are the primary cause of death and the leading cause
of disability in industrialized countries. Dyslipidemia is a major independent and reversible …

Atherosclerosis, a chronic progressive inflammatory condition characterized by the formation
of lipid-laden lesions in arterial walls, is associated with substantial morbidity (including …

Hypercholesterolemia is a well-established modifiable cardiovascular risk factor and its
treatment is an essential aim in preventing cardiovascular disease. Current guidelines …

Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins
represent the evidence-based treatment of choice for reducing low-density lipoprotein …